Literature DB >> 2412741

The role of metabolism in the immunogenicity of drugs: production of antibodies to a horseradish peroxidase generated conjugate paracetamol.

J Chesham, G E Davies.   

Abstract

The allergic response to small chemically inert molecules in thought to require their enzymatic conversion to reactive metabolites which are then endowed with the capacity to bind covalently to host proteins and produce immunogenic hapten-carrier conjugates. In contrast to previous studies in which hapten-carrier conjugates have been generated following chemical modification of drugs we have examined the immunogenicity of paracetamol following direct conjugation to carrier proteins with horseradish peroxidase (HRP). Highly substituted conjugates of paracetamol with keyhole limpet haemocyanin (KLH) or bovine serum albumin (BSA) were generated using HRP. The KLH conjugate was used to immunize Balb/C mice. IgM and IgG (predominantly IgG1) responses were observed and shown by enzyme-linked immunosorbent assay (ELISA) to be hapten-specific. Manipulations of HRP levels permitted substitution of KLH to varying extents with paracetamol. Such conjugates were tested for their ability to induce a hapten-specific immune response. It was determined that substitution of 1 mol of KLH with 700 mol of paracetamol was sufficient to generate an anti-hapten response. These data suggest a mechanism by which protein-non-reactive drugs may be rendered immunogenic and provide a method for demonstrating the presence of serum antibodies reactive with drug metabolites.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412741      PMCID: PMC1577289     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation.

Authors:  N A Mitchison
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

2.  Irreversible protein binding of [14-C]imipramine with rat and human liver microsomes.

Authors:  H Kappus; H Remmer
Journal:  Biochem Pharmacol       Date:  1975-05-15       Impact factor: 5.858

3.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo.

Authors:  D J Jollow; J R Mitchell; W Z Potter; D C Davis; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

Review 4.  Immunochemical mechanisms of drug allergy.

Authors:  B B Levine
Journal:  Annu Rev Med       Date:  1966       Impact factor: 13.739

5.  A microsome-dependent binding of benzo[a]pyrene to DNA.

Authors:  H V Gelboin
Journal:  Cancer Res       Date:  1969-06       Impact factor: 12.701

6.  Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro.

Authors:  W Z Potter; D C Davis; J R Mitchell; D J Jollow; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

7.  Hydroperoxide catalyzed liver microsomal aromatic hydroxylation reactions involving cytochrome P-450.

Authors:  A D Rahimtula; P J O'Brien
Journal:  Biochem Biophys Res Commun       Date:  1974-09-09       Impact factor: 3.575

8.  Peroxidase-mediated formation of reactive metabolites of acetaminophen.

Authors:  S D Nelson; D C Dahlin; E J Rauckman; G M Rosen
Journal:  Mol Pharmacol       Date:  1981-07       Impact factor: 4.436

9.  Immune thrombocytopenia due to a drug metabolite.

Authors:  E V Eisner; N T Shahidi
Journal:  N Engl J Med       Date:  1972-08-24       Impact factor: 91.245

10.  Interactions of vinyl chloride with rat-liver DNA in vivo.

Authors:  T Green; D E Hathway
Journal:  Chem Biol Interact       Date:  1978-09       Impact factor: 5.192

View more
  4 in total

1.  Anticarbamazepine antibody induced by carbamazepine in a patient with severe serum sickness.

Authors:  N Hosoda; W Sunaoshi; H Shirai; Y Bando; H Miura; M Igarashi
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

Review 2.  Immunological risk of injectable drug delivery systems.

Authors:  Wim Jiskoot; Rianne M F van Schie; Myrra G Carstens; Huub Schellekens
Journal:  Pharm Res       Date:  2009-02-27       Impact factor: 4.200

3.  The specificity of murine polyclonal and monoclonal antibodies to the haptenic drug chlorhexidine induced by chlorine-generated chlorhexidine-protein conjugates.

Authors:  G T Layton; D R Stanworth; H E Amos
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

4.  Prevalence of anti-Neu5Gc antibodies in patients with hypothyroidism.

Authors:  Phaedra Eleftheriou; Stavros Kynigopoulos; Alexandra Giovou; Alexandra Mazmanidi; John Yovos; Petros Skepastianos; Eleni Vagdatli; Christos Petrou; Dafni Papara; Maria Efterpiou
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.